ICU Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2025: 2.19%

ICU Medical, Inc. Return on Capital Employed (ROCE) is 2.19% for the Trailing 12 Months (TTM) ending March 31, 2025, a 424.62% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • ICU Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 0.42%, a 13.23% change year over year.
  • ICU Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 0.37%, a -84.76% change year over year.
  • ICU Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 2.42%, a -66.04% change year over year.
  • ICU Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 7.13%, a -1.59% change year over year.
Key Data
Date Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share